D
InspireMD, Inc.
NSPR
$2.51
-$0.18-6.69%
D
Sell
7/25/2024Upgraded
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 7/25/2024 due to an increase in the volatility index and total return index.
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 7/25/2024 due to an increase in the volatility index and total return index.
E
Sell
7/10/2024Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 7/10/2024 due to a decline in the volatility index.
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 7/10/2024 due to a decline in the volatility index.
D
Sell
6/18/2024Upgraded
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 6/18/2024 due to an increase in the volatility index.
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 6/18/2024 due to an increase in the volatility index.
E
Sell
6/3/2024Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 6/3/2024 due to a decline in the volatility index, solvency index and valuation index. Debt to equity increased from 0.01 to 0.02.
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 6/3/2024 due to a decline in the volatility index, solvency index and valuation index. Debt to equity increased from 0.01 to 0.02.
D
Sell
5/21/2024Upgraded
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 5/21/2024 due to an increase in the volatility index and total return index.
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 5/21/2024 due to an increase in the volatility index and total return index.
E
Sell
5/3/2024Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 5/3/2024 due to a decline in the volatility index.
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 5/3/2024 due to a decline in the volatility index.
D
Sell
4/18/2024Upgraded
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 4/18/2024 due to an increase in the volatility index.
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 4/18/2024 due to an increase in the volatility index.
E
Sell
3/28/2024Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 3/28/2024 due to a decline in the volatility index and total return index.
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 3/28/2024 due to a decline in the volatility index and total return index.
D
Sell
3/12/2024Upgraded
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 3/12/2024 due to an increase in the volatility index and growth index. Total revenue increased 13.17% from $1.56M to $1.76M.
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 3/12/2024 due to an increase in the volatility index and growth index. Total revenue increased 13.17% from $1.56M to $1.76M.
E
Sell
3/7/2024Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 3/7/2024 due to a decline in the volatility index, growth index and valuation index. Operating cash flow declined 21.59% from -$3.33M to -$4.04M, EBIT declined 6.1% from -$5.32M to -$5.64M, and total revenue declined 5.64% from $1.65M to $1.56M.
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 3/7/2024 due to a decline in the volatility index, growth index and valuation index. Operating cash flow declined 21.59% from -$3.33M to -$4.04M, EBIT declined 6.1% from -$5.32M to -$5.64M, and total revenue declined 5.64% from $1.65M to $1.56M.
D
Sell
6/20/2023Upgraded
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 6/20/2023 due to an increase in the volatility index and total return index.
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 6/20/2023 due to an increase in the volatility index and total return index.
E
Sell
6/5/2023Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 6/5/2023 due to a decline in the volatility index and solvency index. Debt to equity increased from 0.02 to 0.03, and the quick ratio declined from 3.76 to 3.33.
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 6/5/2023 due to a decline in the volatility index and solvency index. Debt to equity increased from 0.02 to 0.03, and the quick ratio declined from 3.76 to 3.33.
D
Sell
5/17/2023Upgraded
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 5/17/2023 due to an increase in the total return index and volatility index.
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 5/17/2023 due to an increase in the total return index and volatility index.
E
Sell
3/14/2023Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D on 03/14/2023.
InspireMD, Inc. (NSPR) was downgraded to E+ from D on 03/14/2023.
D
Sell
2/9/2023Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
InspireMD, Inc. (NSPR) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index.
InspireMD, Inc. (NSPR) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index.
D
Sell
1/26/2023Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from D- on 1/26/2023 due to an increase in the volatility index.
InspireMD, Inc. (NSPR) was upgraded to D from D- on 1/26/2023 due to an increase in the volatility index.
D
Sell
1/10/2023Downgrade
InspireMD, Inc. (NSPR) was downgraded to D- from D on 1/10/2023 due to a decline in the volatility index and total return index.
InspireMD, Inc. (NSPR) was downgraded to D- from D on 1/10/2023 due to a decline in the volatility index and total return index.
D
Sell
12/19/2022Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from D- on 12/19/2022 due to an increase in the volatility index.
InspireMD, Inc. (NSPR) was upgraded to D from D- on 12/19/2022 due to an increase in the volatility index.
D
Sell
12/2/2022Downgrade
InspireMD, Inc. (NSPR) was downgraded to D- from D on 12/2/2022 due to a decline in the volatility index and total return index.
InspireMD, Inc. (NSPR) was downgraded to D- from D on 12/2/2022 due to a decline in the volatility index and total return index.
D
Sell
11/14/2022Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from D- on 11/14/2022 due to an increase in the volatility index and growth index. Earnings per share increased from -$0.5938 to -$0.5778, and EBIT increased 1.52% from -$4.68M to -$4.61M.
InspireMD, Inc. (NSPR) was upgraded to D from D- on 11/14/2022 due to an increase in the volatility index and growth index. Earnings per share increased from -$0.5938 to -$0.5778, and EBIT increased 1.52% from -$4.68M to -$4.61M.
D
Sell
11/10/2022Downgrade
InspireMD, Inc. (NSPR) was downgraded to D- from D on 11/10/2022 due to a decline in the volatility index and total return index.
InspireMD, Inc. (NSPR) was downgraded to D- from D on 11/10/2022 due to a decline in the volatility index and total return index.
D
Sell
10/21/2022Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from D- on 10/21/2022 due to an increase in the volatility index.
InspireMD, Inc. (NSPR) was upgraded to D from D- on 10/21/2022 due to an increase in the volatility index.
D
Sell
10/6/2022Downgrade
InspireMD, Inc. (NSPR) was downgraded to D- from D on 10/6/2022 due to a decline in the volatility index.
InspireMD, Inc. (NSPR) was downgraded to D- from D on 10/6/2022 due to a decline in the volatility index.
D
Sell
9/9/2022Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from D- on 9/9/2022 due to an increase in the volatility index and total return index.
InspireMD, Inc. (NSPR) was upgraded to D from D- on 9/9/2022 due to an increase in the volatility index and total return index.
D
Sell
8/24/2022Downgrade
InspireMD, Inc. (NSPR) was downgraded to D- from D on 8/24/2022 due to a decline in the solvency index and volatility index. Debt to equity increased from 0.01 to 0.02, and the quick ratio declined from 8.41 to 5.91.
InspireMD, Inc. (NSPR) was downgraded to D- from D on 8/24/2022 due to a decline in the solvency index and volatility index. Debt to equity increased from 0.01 to 0.02, and the quick ratio declined from 8.41 to 5.91.
D
Sell
6/13/2022Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from D- on 6/13/2022 due to an increase in the volatility index.
InspireMD, Inc. (NSPR) was upgraded to D from D- on 6/13/2022 due to an increase in the volatility index.
D
Sell
5/27/2022Downgrade
InspireMD, Inc. (NSPR) was downgraded to D- from D on 5/27/2022 due to a decline in the solvency index, volatility index and total return index.
InspireMD, Inc. (NSPR) was downgraded to D- from D on 5/27/2022 due to a decline in the solvency index, volatility index and total return index.
D
Sell
5/16/2022Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
InspireMD, Inc. (NSPR) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
InspireMD, Inc. (NSPR) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell
5/4/2022Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
InspireMD, Inc. (NSPR) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
E
Sell
5/1/2022Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
InspireMD, Inc. (NSPR) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from E+ on 04/21/2022.
InspireMD, Inc. (NSPR) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D on 4/20/2022 due to a decline in the valuation index.
InspireMD, Inc. (NSPR) was downgraded to E+ from D on 4/20/2022 due to a decline in the valuation index.
D
Sell
1/11/2022Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from D- on 1/11/2022 due to an increase in the volatility index and valuation index.
InspireMD, Inc. (NSPR) was upgraded to D from D- on 1/11/2022 due to an increase in the volatility index and valuation index.
D
Sell
11/10/2021Downgrade
InspireMD, Inc. (NSPR) was downgraded to D- from D on 11/10/2021 due to a decline in the growth index, solvency index and valuation index. The quick ratio declined from 11.56 to 3.81, operating cash flow declined 63.77% from -$2.53M to -$4.14M, and EBIT declined 17.18% from -$3.44M to -$4.03M.
InspireMD, Inc. (NSPR) was downgraded to D- from D on 11/10/2021 due to a decline in the growth index, solvency index and valuation index. The quick ratio declined from 11.56 to 3.81, operating cash flow declined 63.77% from -$2.53M to -$4.14M, and EBIT declined 17.18% from -$3.44M to -$4.03M.
D
Sell
11/9/2021Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from E+ on 11/09/2021.
InspireMD, Inc. (NSPR) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D on 11/8/2021 due to a decline in the total return index and volatility index.
InspireMD, Inc. (NSPR) was downgraded to E+ from D on 11/8/2021 due to a decline in the total return index and volatility index.
D
Sell
5/12/2021Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from D- on 5/12/2021 due to an increase in the valuation index and growth index. Total revenue increased 536.71% from $158 to $1.01M, earnings per share increased from -$1.5064 to -$0.53, and EBIT increased 10.14% from -$3.69M to -$3.31M.
InspireMD, Inc. (NSPR) was upgraded to D from D- on 5/12/2021 due to an increase in the valuation index and growth index. Total revenue increased 536.71% from $158 to $1.01M, earnings per share increased from -$1.5064 to -$0.53, and EBIT increased 10.14% from -$3.69M to -$3.31M.
D
Sell
4/26/2021Downgrade
InspireMD, Inc. (NSPR) was downgraded to D- from D on 4/26/2021 due to a major decline in the growth index and valuation index. EBIT declined 105.46% from -$1.8M to -$3.69M, total revenue declined 83.88% from $980 to $158, and earnings per share declined from -$0.064 to -$0.1004.
InspireMD, Inc. (NSPR) was downgraded to D- from D on 4/26/2021 due to a major decline in the growth index and valuation index. EBIT declined 105.46% from -$1.8M to -$3.69M, total revenue declined 83.88% from $980 to $158, and earnings per share declined from -$0.064 to -$0.1004.
D
Sell
7/15/2020Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from D- on 7/15/2020 due to an increase in the volatility index.
InspireMD, Inc. (NSPR) was upgraded to D from D- on 7/15/2020 due to an increase in the volatility index.
D
Sell
6/30/2020Downgrade
InspireMD, Inc. (NSPR) was downgraded to D- from D on 6/30/2020 due to a decline in the volatility index.
InspireMD, Inc. (NSPR) was downgraded to D- from D on 6/30/2020 due to a decline in the volatility index.
D
Sell
5/13/2020Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from D- on 5/13/2020 due to a noticeable increase in the growth index. Earnings per share increased from -$0.5747 to -$0.43, EBIT increased 19.35% from -$2.51M to -$2.02M, and total revenue increased 2.07% from $1.01M to $1.03M.
InspireMD, Inc. (NSPR) was upgraded to D from D- on 5/13/2020 due to a noticeable increase in the growth index. Earnings per share increased from -$0.5747 to -$0.43, EBIT increased 19.35% from -$2.51M to -$2.02M, and total revenue increased 2.07% from $1.01M to $1.03M.
D
Sell
5/1/2020Upgraded
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 5/1/2020 due to an increase in the volatility index and solvency index.
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 5/1/2020 due to an increase in the volatility index and solvency index.
E
Sell
11/8/2017Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 11/8/2017 due to a decline in the efficiency index, solvency index and volatility index. Total capital declined 34.17% from $5.74M to $3.78M, and the quick ratio declined from 2.89 to 2.01.
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 11/8/2017 due to a decline in the efficiency index, solvency index and volatility index. Total capital declined 34.17% from $5.74M to $3.78M, and the quick ratio declined from 2.89 to 2.01.
D
Sell
8/9/2017Upgraded
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 8/9/2017 due to an increase in the efficiency index, solvency index and growth index. Earnings per share increased from -$0.6484 to -$0.21, operating cash flow increased 42.35% from -$2.76M to -$1.59M, and total revenue increased 12.48% from $569 to $640.
InspireMD, Inc. (NSPR) was upgraded to D- from E+ on 8/9/2017 due to an increase in the efficiency index, solvency index and growth index. Earnings per share increased from -$0.6484 to -$0.21, operating cash flow increased 42.35% from -$2.76M to -$1.59M, and total revenue increased 12.48% from $569 to $640.
E
Sell
2/17/2017Downgrade
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 2/17/2017 due to a decline in the efficiency index. Total capital declined 31.95% from $9.88M to $6.73M.
InspireMD, Inc. (NSPR) was downgraded to E+ from D- on 2/17/2017 due to a decline in the efficiency index. Total capital declined 31.95% from $9.88M to $6.73M.
D
Sell
11/16/2016Downgrade
InspireMD, Inc. (NSPR) was downgraded to D- from D on 11/16/2016 due to a decline in the growth index, solvency index and volatility index. Operating cash flow declined 272.17% from -$794 to -$2.96M, debt to equity increased from -0.77 to 0.59, and total revenue declined 13.15% from $540 to $469.
InspireMD, Inc. (NSPR) was downgraded to D- from D on 11/16/2016 due to a decline in the growth index, solvency index and volatility index. Operating cash flow declined 272.17% from -$794 to -$2.96M, debt to equity increased from -0.77 to 0.59, and total revenue declined 13.15% from $540 to $469.
D
Sell
3/11/2016Downgrade
InspireMD, Inc. (NSPR) was downgraded to D from D+ on 3/11/2016 due to a substantial decline in the volatility index and total return index.
InspireMD, Inc. (NSPR) was downgraded to D from D+ on 3/11/2016 due to a substantial decline in the volatility index and total return index.
D
Sell
11/10/2015Upgraded
InspireMD, Inc. (NSPR) was upgraded to D+ from D on 11/10/2015 due to an increase in the valuation index, solvency index and growth index. Debt to equity declined from 3.02 to -10.92.
InspireMD, Inc. (NSPR) was upgraded to D+ from D on 11/10/2015 due to an increase in the valuation index, solvency index and growth index. Debt to equity declined from 3.02 to -10.92.
D
Sell
10/15/2015Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from D- on 10/15/2015 due to an increase in the valuation index.
InspireMD, Inc. (NSPR) was upgraded to D from D- on 10/15/2015 due to an increase in the valuation index.
D
Sell
9/30/2015Downgrade
InspireMD, Inc. (NSPR) was downgraded to D- from D on 9/30/2015 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 1.49 to 3.02, and the quick ratio declined from 1.89 to 1.46.
InspireMD, Inc. (NSPR) was downgraded to D- from D on 9/30/2015 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 1.49 to 3.02, and the quick ratio declined from 1.89 to 1.46.
D
Sell
3/13/2015Downgrade
InspireMD, Inc. (NSPR) was downgraded to D from D+ on 3/13/2015 due to a decline in the total return index and volatility index.
InspireMD, Inc. (NSPR) was downgraded to D from D+ on 3/13/2015 due to a decline in the total return index and volatility index.
D
Sell
11/20/2014Upgraded
InspireMD, Inc. (NSPR) was upgraded to D+ from D on 11/20/2014 due to an increase in the valuation index, growth index and volatility index. Total revenue increased 41.45% from $193 to $273, and operating cash flow increased 27.41% from -$4.65M to -$5.92M.
InspireMD, Inc. (NSPR) was upgraded to D+ from D on 11/20/2014 due to an increase in the valuation index, growth index and volatility index. Total revenue increased 41.45% from $193 to $273, and operating cash flow increased 27.41% from -$4.65M to -$5.92M.
D
Sell
8/12/2014Upgraded
InspireMD, Inc. (NSPR) was upgraded to D from D- on 8/12/2014 due to an increase in the total return index.
InspireMD, Inc. (NSPR) was upgraded to D from D- on 8/12/2014 due to an increase in the total return index.
NASDAQ
04/04/2025 12:36PM Eastern
Quotes delayed
